434.924.9333
Patient & Visitor Information

434.924.9333

Cancer Center
Cancers We Treat

See All Cancers We Treat

Need a Second Opinion?

If you'd like to schedule an appointment for a second opinion, call 434.924.9333.

  

Need a Second Opinion?

If you'd like to schedule an appointment for a second opinion, call 434.924.9333.

Questions?

If you need to speak with someone about your appointment, call 434.924.9333.

Construction Update: Temporary Sidewalk Closure

  

Make an Appointment

If you'd like to make an appointment or get a second opinion, call 434.924.9333.

Google Search Cancer

Guidelines and Application

Guidelines for Membership

The goal of the NCI Cancer Center Support Grant is to foster research that will improve the understanding, treatment, and prevention of cancer. We support innovative collaborative and interdisciplinary research including basic, translational, clinical, and population-based research. We encourage investigators with new perspectives and technologies to apply their expertise to the cancer problem. However, the research we support must have a clear and central cancer focus.

Application Process

Investigators wishing to become Members of the University of Virginia Cancer Center should write a 1-2 page letter addressed to Dr. Thomas P. Loughran, Jr., MD, Director of the Cancer Center. Please email the letter to Dina Gould Halme, PhD, Associate Director for Research Program Administration. In the letter, summarize your research program and its cancer relevance. If you are collaborating with other cancer investigators, summarize the collaborations. Also, please attach your NIH biographical sketch or CV, as well as an NIH "Other Support" page, if you have external funding.

Criteria for Membership

To be eligible for Full Membership in the Cancer Center you must be a member of the University of Virginia faculty with a rank of at least Assistant Professor. Instructors and Fellows are not eligible for membership.

Established investigators (rank of Associate Professor or Professor) should demonstrate the following:

  • P.I. on a peer-reviewed funded research grant.
  • In lieu of peer-reviewed funding, clinical investigators should be participating in cancer clinical trials.
  • A demonstrated record in cancer research, including recent publications and or collaborations.

Junior Faculty (rank of Assistant Professor or Assistant Professor of Research) should demonstrate the following:

  • Independent, cancer focused, peer-reviewed funding is preferred, but is not required.
  • In lieu of independent funding, the junior faculty member must demonstrate a strong cancer focus.
  • Documentation of independence such as independent laboratory space, P.I. on externally funded project, primary authorship on peer-reviewed research publications.

Associate Members must display the potential to contribute in a meaningful way to reduce the cancer burden, either through laboratory, clinical, or population-based research, or through education. The Associate Member category includes investigators who enroll patients in cancer clinical trials, but are not PIs, and those whose primary focus is not cancer, but who have expertise that is important in cancer research.

Program Affiliation

The Cancer Center contains five research Programs, each with two Program Co-Leaders. The Program Leaders are:


All applicants are encouraged to go to the Research Programs webpage to determine which Program is best suited to their research interests, and to discuss their membership goals with the relevant Program Leader.

Some members may be unaffiliated. Interested individuals should speak with the Cancer Center Director, Deputy Director, or Associate Directors.

Length of Membership

Cancer Center members that meet the criteria above will be appointed for a period of three years. All Cancer Center investigators will be reviewed every three years. The review will include submission of an "other support" page, a research program summary including publications, and a description of ongoing and planned collaborations with other Cancer Center investigators and participation in Cancer Center activities. Clinical investigators will be asked to also describe their involvement in clinical trials, including trials they have written, helped to open, or accrued patients to.

Thank you for your interest in the Cancer Center. Please contact Dina Gould Halme, PhD, Associate Director for Research Program Administration, with any questions.